BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Abliva - ECPv6.15.14//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Abliva
X-ORIGINAL-URL:https://abliva.com
X-WR-CALDESC:Händelser för Abliva
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20210428T090000
DTEND;TZID=Europe/Stockholm:20210428T120000
DTSTAMP:20260404T144557
CREATED:20210408T115806Z
LAST-MODIFIED:20210423T112059Z
UID:2651-1619600400-1619611200@abliva.com
SUMMARY:Redeye Orphan Drugs
DESCRIPTION:Abliva kommer att delta vid Redeyes seminarium om ‘Drug development in orphan indications’ (Läkemedelsutveckling inom särläkemedelsindikationer). \nVD Ellen Donnelly kommer att presentera bolaget kl 10:55. Följ länken nedan för ytterligare detaljer samt livesändning.
URL:https://abliva.com/sv/event/redeye-orphan-drugs-2/
LOCATION:Virtual
CATEGORIES:Investerarevent
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2020/11/Girl-doctor.jpg
END:VEVENT
END:VCALENDAR